Please provide your email address to receive an email when new articles are posted on . Adjuvant therapy with exemestane was safer and more effective than tamoxifen in reducing breast cancer ...

January 18, 2011 — Exemestane used alone for 5 years is similar to exemestane used after 2 to 3 years of tamoxifen in the prevention of relapse in postmenopausal women with hormone-responsive early ...

February 6, 2012 — New data from a subset of postmenopausal women participating in a landmark trial that established exemestane for the prevention of breast cancer show that the drug significantly ...

Please provide your email address to receive an email when new articles are posted on . Everolimus plus exemestane resulted in a greater PFS benefit versus everolimus alone in patients with estrogen ...

Review the side-effects of Exemestane as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Absolute Risk Reductions for Local Recurrence After Postoperative Radiotherapy After Sector Resection for Ductal Carcinoma In Situ of the Breast A randomized phase II study was conducted in ...

Selective estrogen-receptor modulators (tamoxifen [Nolvadex, Soltamox], raloxifene [Evista]) have been shown to reduce the risk of breast cancer in postmenopausal women, but also have been associated ...

BRUSSELS, BELGIUM (September 19, 2003) - A study published in the September 2003 issue of Annals of Oncology (vol. 14, issue 9) indicated that exemestane demonstrates a high response rate for ...

Tamoxifen is an estrogen-receptor (ER) antagonist blocking the action of estrogen. The risk–benefit ratio of using tamoxifen for longer than 5 years in the adjuvant setting is still unclear. Aromatase ...

Details concerning the Exemestane medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and injections.